| Direct-to-Consumer Genetic Testing (MDS008B) |
| Colors hereditary cancer test |
|
Color Health hereditary cancer test is a direct-to-consumer genetic test that evaluates an individual’s risk for inherited cancers. It examines specific genetic mutations associated with a higher likelihood of developing cancers such as breast, ovarian, colorectal, pancreatic, melanoma, and prostate. This test is initiated by the consumer under the supervision of a physician. |
| Color’s hereditary heart health test |
|
Color’s Health hereditary heart health test is a direct-to-consumer genetic test designed to evaluate an individual’s risk for inherited heart conditions. It examines specific genetic markers associated with cardiovascular diseases, such as genetic heart diseases, arrhythmias, hypertrophic cardiomyopathy, and familial hypercholesterolemia. This test is initiated by the consumer under the supervision of a physician. |
| Color’s pharmacogenomic (PGx) tests |
|
Color health’s pharmacogenomic (PGx) tests are designed to reveal how a person’s genetic profile can impact their reaction to medications. These tests look at specific genetic variations such as CYP1A2, CYP2D6, CYP2C19, CYP2C9, CYP3A4, etc, that can affect how drugs are processed in the body, their effectiveness, and the risk of experiencing side effects. This test is initiated by the consumer under the supervision of a physician. |
|
